White D G, Hudson C, Maurer J J, Ayers S, Zhao S, Lee M D, Bolton L, Foley T, Sherwood J
North Dakota State University, Fargo, North Dakota, USA.
J Clin Microbiol. 2000 Dec;38(12):4593-8. doi: 10.1128/JCM.38.12.4593-4598.2000.
Florfenicol, a veterinary fluorinated analog of thiamphenicol, is approved for treatment of bovine respiratory pathogens in the United States. However, florfenicol resistance has recently emerged among veterinary Escherichia coli isolates incriminated in bovine diarrhea. The flo gene, which confers resistance to florfenicol and chloramphenicol, has previously been identified in Photobacterium piscicida and Salmonella enterica serovar Typhimurium DT104. The flo gene product is closely related to the CmlA protein identified in Pseudomonas aeruginosa. The cmlA gene confers nonenzymatic chloramphenicol resistance via an efflux mechanism. Forty-eight E. coli isolates recovered from calves with diarrhea, including 41 that were both chloramphenicol and florfenicol resistant, were assayed for the presence of both flo and cmlA genes. Forty-two of the 44 isolates for which florfenicol MICs were > or =16 microg/ml were positive via PCR for the flo gene. All E. coli isolates for which florfenicol MICs were < or =8 microg/ml were negative for the flo gene (n = 4) Twelve E. coli isolates were positive for cmlA, and chloramphenicol MICs for all 12 were > or =32 microg/ml. Additionally, eight isolates were positive for both flo and cmlA, and both florfenicol and chloramphenicol MICs for these isolates were > or =64 microg/ml. DNA sequence analysis of the E. coli flo gene demonstrated 98% identity to the published GenBank sequences of both serovar Typhimurium flo(St) and P. piscicida pp-flo. The flo gene was identified on high-molecular-weight plasmids of approximately 225 kb among the majority of florfenicol-resistant E. coli isolates. However, not all of the florfenicol-resistant E. coli isolates tested contained the large flo-positive plasmids. This suggests that several of the E. coli isolates may possess a chromosomal flo gene. The E. coli flo gene specifies nonenzymatic cross-resistance to both florfenicol and chloramphenicol, and its presence among bovine E. coli isolates of diverse genetic backgrounds indicates a distribution much wider than previously thought.
氟苯尼考是甲砜霉素的一种兽用氟化类似物,在美国被批准用于治疗牛呼吸道病原体。然而,最近在引起牛腹泻的兽用大肠杆菌分离株中出现了氟苯尼考耐药性。赋予对氟苯尼考和氯霉素耐药性的flo基因先前已在杀鱼发光杆菌和鼠伤寒沙门氏菌血清型鼠伤寒DT104中被鉴定出来。flo基因产物与在铜绿假单胞菌中鉴定出的CmlA蛋白密切相关。cmlA基因通过外排机制赋予非酶促氯霉素耐药性。对从腹泻犊牛中分离出的48株大肠杆菌进行检测,包括41株对氯霉素和氟苯尼考均耐药的菌株,以检测flo和cmlA基因的存在情况。在44株氟苯尼考MIC≥16μg/ml的分离株中,有42株通过PCR检测flo基因为阳性。所有氟苯尼考MIC≤8μg/ml的大肠杆菌分离株flo基因为阴性(n = 4)。12株大肠杆菌分离株cmlA为阳性,所有12株的氯霉素MIC≥32μg/ml。此外, 8株分离株flo和cmlA均为阳性,这些分离株的氟苯尼考和氯霉素MIC均≥64μg/ml。对大肠杆菌flo基因的DNA序列分析表明,与已发表的鼠伤寒血清型flo(St)和杀鱼发光杆菌pp-flo的GenBank序列有98%的同一性。在大多数耐氟苯尼考的大肠杆菌分离株中,flo基因存在于约225 kb的高分子量质粒上。然而,并非所有检测的耐氟苯尼考大肠杆菌分离株都含有大的flo阳性质粒。这表明一些大肠杆菌分离株可能拥有染色体flo基因。大肠杆菌flo基因赋予对氟苯尼考和氯霉素的非酶促交叉耐药性,其在不同遗传背景的牛大肠杆菌分离株中的存在表明其分布比以前认为的要广泛得多。